Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROMIPLOSTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROMIPLOSTIM: Safety Overview

Metric RIZATRIPTAN ROMIPLOSTIM
Total FAERS Reports 2,896 7,510
Deaths Reported 68 865
Death Rate 2.3% 11.5%
Hospitalizations 479 1,812
Average Patient Age 44.6 yrs 56.7 yrs
% Female Patients 77.2% 55.7%
FDA Approval Date Apr 14, 2023 N/A
Manufacturer Panacea Biotec Limited Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription